GINA BEARDEN: Open Payments
NPI 1689774291 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 51 payments from 18 companies in 2025. Trend: 2023 $1,970 · 2024 $1,140 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $176 |
| Xeris Pharmaceuticals, Inc. | 6 | $127 |
| Insulet Corporation | 5 | $115 |
| Radius Health, Inc. | 4 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Abbott Laboratories | 3 | $46 |
| Lilly USA, LLC | 3 | $42 |
| Novo Nordisk Inc | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| CeQur Corporation | 1 | $31 |
Products named: LEQVIO, Omnipod, RECORLEV, Tymlos, Kerendia, FREESTYLE LIBRE 3, JARDIANCE, Wegovy.
Industry payments across TN — which companies pay providers there.
